AVITA Medical, Inc.RCELEarnings & Financial Report
Nasdaq · health care industry
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 7.10% | 1.8M | — | 2024-01-26 |
| The Vanguard Group | 5.45% | 1.4M | — | 2024-02-13 |
Insider Transactions
Net 90d: +$21.1K · buys $21.1K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-11 | O'Toole David D | CFO | Buy (open market) | 1.8K | $4.78 | $8.6K |
| 2026-02-19 | O'Toole David D | CFO | Buy (open market) | 3.0K | $4.15 | $12.5K |
| 2026-02-18 | O'Toole David D | CFO | Grant | 105.5K | — | — |
| 2026-02-18 | KELSEY NICOLE | Chief Legal Officer | Grant | 98.4K | — | — |
1–4 of 4